Home   News   Article

Subscribe Now

University Alzheimer’s drug human trials boost

Prof David Alsop
Prof David Alsop

Lancaster University scientists are celebrating a major breakthrough with a revolutionary new drug that could prevent the early stages of Alzheimer’s for thousands of people worldwide.

The news, announced during Dementia Awareness Week From May 17-23, means that the drug will now be tested on humans.

It is encouraging that our drug is being taken forward and will be tested on humans
Professor David Allsop

Lancaster University has filed a patent application and the drug will be progressing into clinical trials run by the North West research company MAC Clinical Research.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More